テネシーにおける軟部組織肉腫の臨床試験
テネシー内の拠点で、軟部組織肉腫に関する19件の研究が参加者を募集しています。
テネシー内の都市
公式研究テキスト（英語）
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
- St. Jude Children's Research Hospital, Memphis
被験者募集中第1/2相
25歳以下 · 全性別 · 2026/09/25更新 · NCT04094610Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
- Sarah Cannon Tennessee Oncology, Nashville
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/08更新 · NCT05732831Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
- Vanderbilt University School of Medicine, Nashville
被験者募集中第1相
12歳〜85歳 · 全性別 · 2026/09/08更新 · NCT03715933First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors
- Sarah Cannon Research Institute, Nashville
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/04更新 · NCT06644755A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- SCRI Oncology Partners, Nashville
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/03更新 · NCT06760819Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma
- St. Jude Children's Research Hospital, Memphis
被験者募集中
全年齢 · 全性別 · 2026/08/21更新 · NCT07514819Enhanced Recovery After Surgery in Extremity Sarcoma
- Vanderbilt University Medical Center, Nashville
被験者募集中
18歳以上 · 全性別 · 2026/08/21更新 · NCT04461171NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
- St. Jude Children's Research Hospital, Memphis
被験者募集中第1/2相
30歳以下 · 全性別 · 2026/08/03更新 · NCT06239272Deep Phenotyping Gait Deficits in Orthopedic Manifestations of Pediatric Cancer Patients
- St. Jude Children's Research Hospital, Memphis
被験者募集中観察研究健康なボランティア歓迎
5歳〜20歳 · 全性別 · 2026/06/18更新 · NCT07502885A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- Baptist Memorial Hospital Baptist Cancer Center, Memphis
被験者募集中第1/2相
12歳以上 · 全性別 · 2026/05/27更新 · NCT03093116B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
- St. Jude Children's Research Hospital, Memphis
被験者募集中第1相
21歳以下 · 全性別 · 2026/05/19更新 · NCT04897321Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
- St. Jude Children's Research Hospital, Memphis
被験者募集中第1/2相
12 Months – 30 Years · 全性別 · 2026/05/19更新 · NCT04901702Hypofractionated Radiation in Combination With B7-H3-CAR T Cells for Pediatric Patients With Relapsed/Refractory Sarcomas
- St. Jude Children's Research Hospital, Memphis
被験者募集中第1相
21歳以下 · 全性別 · 2026/02/09更新 · NCT07222735Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
- St. Jude Children's Research Hospital, Memphis
被験者募集中第1/2相
2歳〜30歳 · 全性別 · 2026/02/03更新 · NCT05734066cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Baptist (BHMCC), Memphis
- Vanderbilt-Ingram Cancer Center, Nashville
被験者募集中観察研究健康なボランティア歓迎
40歳以上 · 全性別 · 2026/01/20更新 · NCT05366881Molecular Analysis Of Solid Tumors
- St. Jude Children's Research Hospital, Memphis
被験者募集中観察研究
25歳以下 · 全性別 · 2025/11/12更新 · NCT01050296Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan
- Vanderbilt University/Ingram Cancer Center, Nashville
被験者募集中観察研究健康なボランティア歓迎
全年齢 · 全性別 · 2025/09/19更新 · NCT06482957Hypofractionated Radiotherapy Followed by Surgical Resection in the Treatment of Soft Tissue Sarcomas
- Vanderbilt-Ingram Cancer Center, Nashville
被験者募集中第2相
18歳以上 · 全性別 · 2025/03/28更新 · NCT04506008ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。